EBA supports cancellation of law on obligatory licensing of medicine imports
Kyiv, February 21 (Interfax-Ukraine) - The European Business Association (EBA) has supported the cancellation of a law adopted by the parliament in July 2012, which foresees the licensing of imported medicines from March 1 this year, the executive director of the EBA health committee, Natalia Serhiyenko, has said at a press conference at Interfax -Ukraine.
The representatives of the American Chamber of Commerce and the Association of Pharmaceutical Research and Development (APRaD), who were present at the press conference, supported the position.
According to Head of the APRaD Board of Directors Vitaliy Hordiyenko, it is needed to pay for licenses and additional expenses, respectively, might affect the final price of medicines for end consumers.
Besides, he said that Ukraine introduced a mechanism to control medicine quality and there is no sense in taking additional measures. In addition, patients, who will not have access to needed remedies, might suffer during the transition period (until importers get licenses).
"If there is a problem, there should be solutions. The first way is the abolition of the law. Unfortunately, taking into account the situation in the parliament, today it is physically impossible. Therefore, as an interim measure, we can offer the introduction of the most simplified licensing procedure," he said.